MetLife Investment Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,200
| Closed | -$70.5K | – | 2898 |
|
|
2024
Q1 | $70.5K | Buy |
+1,200
| New | +$70.5K | ﹤0.01% | 2665 |
|
|
2023
Q3 | – | Sell |
-1,946
| Closed | -$131K | – | 2918 |
|
|
2023
Q2 | $131K | Buy |
1,946
+54
| +3% | +$3.64K | ﹤0.01% | 2525 |
|
|
2023
Q1 | $883K | Hold |
1,892
| – | – | 0.01% | 1279 |
|
|
2022
Q4 | $758K | Hold |
1,892
| – | – | 0.01% | 1367 |
|
|
2022
Q3 | $615K | Hold |
1,892
| – | – | 0.01% | 1480 |
|
|
2022
Q2 | $500K | Hold |
1,892
| – | – | ﹤0.01% | 1660 |
|
|
2022
Q1 | $569K | Buy |
1,892
+674
| +55% | +$203K | ﹤0.01% | 1692 |
|
|
2021
Q4 | $429K | Buy |
1,218
+220
| +22% | +$77.6K | ﹤0.01% | 1586 |
|
|
2021
Q3 | $255K | Sell |
998
-280
| -22% | -$71.5K | ﹤0.01% | 1935 |
|
|
2021
Q2 | $851K | Hold |
1,278
| – | – | 0.01% | 1263 |
|
|
2021
Q1 | $1.11M | Sell |
1,278
-96
| -7% | -$83.3K | 0.01% | 1108 |
|
|
2020
Q4 | $1.27M | Sell |
1,374
-91
| -6% | -$84.4K | 0.01% | 1025 |
|
|
2020
Q3 | $1.51M | Hold |
1,465
| – | – | 0.02% | 845 |
|
|
2020
Q2 | $1.48M | Buy |
1,465
+75
| +5% | +$76K | 0.02% | 855 |
|
|
2020
Q1 | $1.21M | Hold |
1,390
| – | – | 0.02% | 821 |
|
|
2019
Q4 | $1.49M | Hold |
1,390
| – | – | 0.02% | 925 |
|
|
2019
Q3 | $1.28M | Hold |
1,390
| – | – | 0.01% | 957 |
|
|
2019
Q2 | $1.57M | Buy |
1,390
+56
| +4% | +$63.2K | 0.02% | 917 |
|
|
2019
Q1 | $1.81M | Hold |
1,334
| – | – | 0.02% | 858 |
|
|
2018
Q4 | $1.54M | Buy |
1,334
+44
| +3% | +$50.9K | 0.02% | 868 |
|
|
2018
Q3 | $1.96M | Sell |
1,290
-74
| -5% | -$112K | 0.02% | 869 |
|
|
2018
Q2 | $2.14M | Buy |
1,364
+116
| +9% | +$182K | 0.03% | 771 |
|
|
2018
Q1 | $1.44M | Hold |
1,248
| – | – | 0.02% | 878 |
|
|
2017
Q4 | $1.48M | Buy |
+1,248
| New | +$1.48M | 0.02% | 874 |
|